What is NUVAXOVID JN.1 DISPERSION INYECTABLE used for?

( ARTG ) NUVAXOVID has approval for the indication: Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 12 years of age and older. The use of this vaccine should be in accordance with official recommendations.

What are the side effects of NUVAXOVID JN.1 DISPERSION INYECTABLE?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can NUVAXOVID JN.1 DISPERSION INYECTABLE be used during pregnancy?

( AHT ) For the active ingredient covid-19 (nvx-cov2373) vaccine You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

OTC

NUVAXOVID JN.1 DISPERSION INYECTABLE

INN: NUVAXOVID JN.1 DISPERSION INYECTABLE

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇪🇸

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.